Literature DB >> 28058489

Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy.

Nicolas Belhomme1, Adel Maamar2, Thomas Le Gallou3, Marie-Christine Minot-Myhié4, Antoine Larralde5, Nicolas Champtiaux6,7, Olivier Benveniste6,7, Sarah Leonard-Louis8, Olivier Decaux3, Alain Lescoat3, Yves Le Tulzo9,10.   

Abstract

Entities:  

Keywords:  Chemotherapy; Electron microscopy; Heart failure; Monoclonal gammopathy of unknown significance; Nemaline myopathy related cardiomyopathy; Sarcoplasmic rods; Sporadic late onset nemaline myopathy

Mesh：

Substances：

Year:  2017        PMID： 28058489     DOI： 10.1007/s00277-016-2916-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

2.  Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.

Authors:  Rouslan Kotchetkov; Anna Dyszkiewicz-Korpanty; Vishal Kukreti
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

3.  Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure.

Authors:  Casmir Turnquist; Joanna C Grogono; Monika Hofer; Alex Pitcher
Journal:  Eur Heart J Case Rep       Date:  2020-12-22

4.  Impact of hematologic complete response in the treatment of sporadic late-onset nemaline myopathy associated with monoclonal gammopathy.

Authors:  Tânia Maia; Rui Bergantim; Henrique Costa; Jorge Pinheiro; Fernanda Trigo
Journal:  Clin Case Rep       Date:  2021-07-16

5.  Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.

Authors:  Jantima Tanboon; Akinori Uruha; Yukie Arahata; Carsten Dittmayer; Leonille Schweizer; Hans-Hilmar Goebel; Ichizo Nishino; Werner Stenzel
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.